new drug for HIV, Ziagen (abacavir)
August 1999
Glaxo is now marketing a new drug for HIV, Ziagen (abacavir).
It's a potent nucleoside analog...in the same class as Retrovir (zidovudine) or 3TC (lamivudine).
It'll be used in combo therapy with other antiretrovirals.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote